Navigation Links
Amicus Therapeutics to Present at Lazard Capital Markets Healthcare Conference
Date:11/11/2008

CRANBURY, N.J., Nov. 11 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD), today announced President and CEO, John F. Crowley, will make a presentation at the 5th Annual Lazard Capital Markets Healthcare Conference in New York on Tuesday, November 18, 2008, at 5:10 p.m. EST.

A webcast and audio archive of the presentation will be available at the Company's Web site at http://www.amicustherapeutics.com. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the Company's Web site for 30 days until December 18, 2008.

About Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera for the treatment of Gaucher disease and AT2220 for the treatment of Pompe disease.

Amicus' press releases are available at http://www.amicustherapeutics.com

FOLD -G


'/>"/>
SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
11. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...mbassador to Speak at Economic Club of Canada , ...ember 25, 2009 -- Ambassador to Speak at Economic ... Ambassador for International Investment, and Chai...ew a biography of David Appia go to www.investinf...able to meet with press to discuss recent pro-busi...
(Date:11/25/2009)...v. 25 /PRNewswire/ - Cytochroma today announced th...Directors. Dr. Moldt will replace Mr. Ulrik Spork ...ard. The number of Board members remains unchanged...come Peter Moldt to the board and look forward to ...ochroma continues to make progress in becoming a l...
(Date:11/25/2009)... Nov. 25 Reportlinker.com announce...n its catalogue: ,, Brazil Bioethanol Market A...eportlinker.com/p0165503/Brazil-Bioethanol-Market-...Bioethanol Market Analysis and Forecasts to 2013 ,...analysis and forecasts of the global bioethanol ma...
(Date:11/24/2009)...e in German . , Whether it,s CD packaging, ...io Frequency Identification) are increasingly find...sible to label objects or goods and identify them ...scanner can read and process the data contained in...nder production conditions of up to 100 degrees Ce...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10Intelligence inside metal components 2
...rporation (NYSE: EW ), a world leader in products... disease, will host its Annual Meeting of,Stockhol....m. PT (1:00 pm,ET) at the corporate headquarters ...ting will be available to all interested,parties o...site at, http://www.edwards.com/InvestorRelations/...
...c. (Nasdaq: RNVS ) announced today that its stock...ent with Evotec AG (Frankfurt Stock Exchange:,EVT)...The merger is,expected to close by May 5, 2008., ...are of Renovis common,stock will be automatically ...merican Depositary Share (ADSs) of Evotec, with ea...
...tic Life Sciences Inc.,("ProMetic") (TSX:PLI) will...rs on Wednesday, May 7, 2008 at 10:30 a.m. (EDT). ...eeting") will be held at the Montreal,Museum of Fi...Montreal.,Points to be covered are:, - Items on ...tion Circular - Corporate Presentations, - ...
Other Biology Technology:Edwards Lifesciences to Webcast Annual Stockholders Meeting 2Renovis Stockholders Approve Acquisition by Evotec 2Prometic provides information for its Annual and Special Meeting of Shareholders 2
(Date:11/26/2009)... , Prized for their impressive antlers, red deer ...tions. But a deer,s antlers are much more than dec...together when duelling. John Currey, from The Univ...anical properties of bone for over half a century ...ties of antler through a long-standing collaborati...
(Date:11/26/2009)... , MRSA (methicillin-resistant Staphylococcus Au...e annihilation as low-temperature plasma prototype... easy and unfailing bactericidal cocktails. , Tw...fficient disinfection of healthy skin (e.g. hands ...teria can pose a lethal threat; and another to sho...
(Date:11/25/2009)... , Dr. Sarit Larisch, Head of the Cell Death Re...artment of Biology, has been awarded the prestigio... research exploring the cause of brain cell damage...ed each year to scientists in support of innovatio..., and officially conferred earlier this month at a...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Smoking Bans Reduce Heart Attacks 3A Study 59555 1Smoking Bans Reduce Heart Attacks 3A Study 59555 2Smoking Bans Reduce Heart Attacks 3A Study 59555 3Vicon Signs License Agreement with Microsoft to Develop New Medical Technology 59552 1Vicon Signs License Agreement with Microsoft to Develop New Medical Technology 59552 2Vicon Signs License Agreement with Microsoft to Develop New Medical Technology 59552 3Dr Oz Host of The Dr Oz Show to Accept Honorary CLIO Healthcare Award Live at Nielsens First Ever CLIO Healthcare Awards Mixer 59549 1Dr Oz Host of The Dr Oz Show to Accept Honorary CLIO Healthcare Award Live at Nielsens First Ever CLIO Healthcare Awards Mixer 59549 2Dr Oz Host of The Dr Oz Show to Accept Honorary CLIO Healthcare Award Live at Nielsens First Ever CLIO Healthcare Awards Mixer 59549 3
...Boston, MA Current research suggests that lowerin...ors. The related report by Solomon et al, "Ezetim...s in the March 2009 issue of The American Journal... to atherosclerosis and heart disease, but may als...ostate cancer is the most common non-skin cancer i...
...Madison, WI, February 24, 2009 | Tiny sediment gra...mixture of minerals in an open fabric that results...ween the grains. Scientists at the U.S. Geological... and finding that the mineral composition of these...ne (i.e., between land surface and the water table...
...A Canadian scientist, now based in the UK and fund... Research Council, has harnessed a new drug discov...sulin secretion process. This finding could spark ...abetes. , In work published this week in Nature...f Oxford, led by University of Saskatchewan gradua...
Other Biology News:Lowering your cholesterol may decrease your risk of cancer 2Ultra-fine coatings on sediment grains influence nitrate and sulfate storage in soil 2Canadian scientist mines drugs database for new diabetes treatment 2
Goat Anti-Horse IgG(T) Polyclonal Antibody, Unconjugated from Bethyl Laboratories
Goat Anti-Human STMN2 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-RNase L Monoclonal Antibody, Unconjugated, Clone 2E9 from Novus Biologicals
Rabbit Anti-Porcine Vitronectin Antibody, Unconjugated from Cosmo Bio Co., Ltd.
Biology Products: